Dr. Kyle R. McClintock, DO

Dr. McClintock practices at Sierra Medical Partnership in Folsom, California.

Dr. McClintock's NPI, 1477831527, was assigned on July 22, 2011. Dr. McClintock graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2011. Dr. McClintock holds California license 20A15548.

Dr. McClintock's primary practice is Sierra Medical Partnership, at 1625 Creekside Dr, Folsom, CA 95630 in Sacramento County. The practice phone is (916) 365-2987.

Dr. McClintock's primary practice is Sierra Medical Partnership in Folsom, California. Dr. McClintock is also affiliated with Mercy Hospital of Folsom. The medical group on file is The Sierra Medical Partnership. Dmand AI also links Dr. McClintock to 4 more hospitals, 5 medical groups, 3 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McClintock practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. McClintock's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. McClintock is board certified in orthopedic surgery by the AOA Board of Orthopedic Surgery. Dmand AI has Dr. McClintock's licenses on file in 4 states: California, Arizona, Colorado and Missouri.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, hip replacement and joint arthropathy among the conditions Dr. McClintock treats.

CMS data shows 1,988 Medicare services from Dr. McClintock across 18 procedure codes in 2024, for 476 Medicare patients. Medicare paid $193,078 for them.

CMS counts 476 Medicare patients who saw Dr. McClintock in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have arthritis, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McClintock's median patient age at 63, with 49% women.

In 2024, Dr. McClintock wrote 544 Medicare Part D claims for 219 patients. 99% of them were for generic drugs. CMS names the drug for 466 of them, across 7 drugs with 11 or more claims each, at $2,288 in total drug cost. In 2023, CMS named 307 claims across 9 drugs.

Dr. McClintock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 107 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. McClintock, more than 96% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. McClintock to 1 clinical trial.

CMS Open Payments shows 155 general payments to Dr. McClintock from 23 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 57% of the total. Zimmer Biomet Holdings, Inc. paid the most, $45,628.

Dmand AI lists 3 awards for Dr. McClintock, most recently Fellow of the American Academy of Orthopedic Surgeons in 2023.

Dr. McClintock graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2011. Dr. McClintock is a member of AAOS, AMA, AOA and AANA.

Dr. McClintock is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.